The assay will use Genomic Vision technology and be used to study the role of telomere length in complex diseases.
The companies are accelerating the pace of an existing collaboration with the goal of detecting SMA "2+0" carrier status.
AmCare Genomics said that it has a large network that would enable it to raise awareness about Genomic Vision's test for facioscapulohumeral muscular dystrophy.
The growth was driven in part by a strong increase in revenues for the company's life sciences research products.
APG Bio will distribute the products and services to life science researchers in China, Hong Kong, and Macau.
The company attributed the decline to lower revenues from its collaboration with Quest Diagnostics.
Product sales rose nearly 23 percent during the year, but this was offset by a 34 percent dip in revenue from an R&D collaboration with Quest Diagnostics.
The French molecular diagnostics company said almost 95 percent of its revenue during the quarter came from its R&D collaboration with Quest Diagnostics.
The company and the hospital will conduct a clinical study into the detection and prevention of the disease.
Under the arrangement, the partners will use Genomic Vision's molecular combing technology to identify genetic variations underlying different diseases.
Wired reports on how genetic genealogy's use in forensics has exploded in the year since an arrest in the Golden State Killer case was made.
Retraction Watch reports that the increase in retracted papers at a journal is due to more resources there to tackle publication ethics.
New York City has settled with a forensic scientist who was fired after questioning a DNA testing approach used by the medical examiner's office, the New York Times reports.
In Nature this week: technique for measuring replication fork movement, WINTHER trial results, and more.